Serina Therapeutics SER
NYSE SER
$2.00 -0.01 (-0.48%)
As of: Oct 1, 2026 · 3:14 PM EDT

Serina Therapeutics (SER) Current Leases (2023 - 2024)

Updated

Serina Therapeutics (SER) recorded Current Leases of $11,000 in Q2 2024, down 54.2% from the prior quarter.

Analysis

Serina Therapeutics (SER) Current Leases (2023 - 2024) Analysis & Trends

At the end of FY2023, Serina Therapeutics reported Current Leases of $36,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.32 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Serina Therapeutics 32.93 Mn -7.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 11,000.00
Mar 31, 2024 24,000.00
Dec 31, 2023 36,000.00
API Access

Serina Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=SER&period=max&api_key=YOUR_API_KEY